AFYIA Diagnostics

AFYIA Diagnostics is a member company of the Innovative Diagnostics group, created in 2023 and specialized in human diagnostics for infectious diseases, particularly in low-resource countries (LMIC). Drawing on cutting-edge technologies (PCR, multiplexing (HRM)), it develops rapid and affordable tests for priority diseases such as tuberculosis and HIV.
The objective of AFYIA Diagnostics is to improve access to diagnostics in limited healthcare environments, as part of the “One Health” approach to overall health.